Kronos Bio, Inc.
KRONDelisted Jun 20, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001741830
Kronos Bio, Inc. was delisted on Jun 20, 2025; its insiders filed their last Form 4 on Jun 20, 2025; 47 institutions reported holding it in 13F filings for Q1 2025, worth $15.8M in total; no superinvestor held it.
Holders of 5% or more of KRON
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Kronos Bio, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Kronos Bio, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
13 Schedule 13D and 13G filings on Kronos Bio, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jun 20, 20254:15 PM ET | Bischofberger Norbert Wand 5 others | 13D/A | 0.00%0 shares | –Below 5% | Jun 20, 2025 | SEC |
| Nov 27, 2023 | Bischofberger Norbert W | 13DOld format | – | – | – | SEC |
| Jul 7, 20234:35 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2023 | Capital World Investors | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2023 | Omega Fund V, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 1, 20234:54 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 17, 2022 | Bischofberger Norbert W | 13G/AOld format | – | – | – | SEC |
| Feb 17, 2022 | Belldegrun Arie | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | Capital World Investors | 13GOld format | – | New | – | SEC |
| Feb 11, 2022 | Capital Research Global Investors | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2022 | Vanguard Group Inc | 13GOld format | – | New | – | SEC |
| Feb 4, 20224:12 PM ET | BlackRock Inc. | 13GOld format | – | New | – | SEC |
| May 4, 2021 | Bischofberger Norbert W | 13GOld format | – | New | – | SEC |
| Feb 16, 2021 | Capital Research Global Investors | 13GOld format | – | New | – | SEC |
| Feb 12, 2021 | Omega Fund V, L.P. | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Kronos Bio, Inc. shares.
No Form 144 notices for Kronos Bio, Inc. are on file.